𝔖 Bobbio Scriptorium
✦   LIBER   ✦

T2018 Innate Immunity and Gastric Cancer Susceptibility. Relevance of Helicobacter pylori Recognition-Related Genes on Gastric Cancer Risk

✍ Scribed by Garcia-Gonzalez, Maria Asuncion; Quintero, Enrique; Nicolás-Pérez, David; Benito, Rafael; Strunk, Mark; Santolaria, Santos; Sopena, Federico; Badia, Maria; Piazuelo, Elena; Jimenez, Pilar; Espinel, Jesus; Campo, Rafael; Manzano, Marisa; Geijo, Fernando; Simón, Miguel A.; Pellise, Maria; González-Huix, Ferrán; Espinós, Jorge C.; Titó, LLúcia; Bujanda, Luis; Zaballa, Manuel; Méndez-Sánchez, Isabel María; Pérez-Aisa, María Angeles; Thomson, Concepción; Lanas, Angel


Book ID
123241233
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
78 KB
Volume
138
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Synergistic effect of HLA class II loci
✍ Takashi Ando; Takeshi Ishikawa; Haruki Kato; Norimasa Yoshida; Yuji Naito; Satos 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 107 KB 👁 2 views

## Abstract It has been reported that polymorphisms of human leukocyte antigen (HLA) genes and several cytokine genes are associated with an increased risk of developing gastric cancer (GC). However, the results of studies from different geographic regions, ethnic groups and study groups are incons

Gastric cancer risk in a Mexican populat
✍ Liviu A. Sicinschi; Lizbeth Lopez-Carrillo; M. Constanza Camargo; Pelayo Correa; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 131 KB 👁 1 views

## Abstract Several polymorphisms of the __IL1B__ and __IL10__ gene promoters have been reported to be associated with gastric cancer risk in Caucasians. However, studies in other populations have shown differing results. We aimed to test for associations between polymorphisms in __IL1B__ (__−31__

Risk of gastric cancer in asymptomatic,
✍ Kimihiko Yanaoka; Masashi Oka; Noriko Yoshimura; Chizu Mukoubayashi; Shotaro Eno 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 224 KB

## Abstract A total of 5,209 asymptomatic, middle‐aged subjects, whose serum pepsinogen (PG) and __Helicobacter pylori__ antibody levels had been assessed, were followed for 10 years. Subjects with positive serum __H. pylori__ antibodies (>50 U/mL) had an increased cancer risk (HR = 3.48, 95% CI =